Celldex Therapeutics Inc (NASDAQ:CLDX)

0.6337
Delayed Data
As of May 25
 -0.0039 / -0.61%
Today’s Change
0.62
Today|||52-Week Range
3.26
-77.69%
Year-to-Date
No recent news for Celldex Therapeutics Inc.

Today’s Trading

Previous close0.64
Today’s open0.64
Day’s range0.62 - 0.65
Volume2,039,192
Average volume (3 months)2,498,964
Market cap$103.2M
Data as of 4:00pm ET, 05/25/2018

Growth & Valuation

Earnings growth (last year)+43.31%
Earnings growth (this year)-53.12%
Earnings growth (next 5 years)--
Revenue growth (last year)+87.78%
P/E ratioNM
Price/Sales28.65
Price/Book0.42

Competitors

 Today’s
change
Today’s
% change
VCYTVeracyte Inc-0.23-2.98%
OXFDOxford Immunotec Glo...+0.29+2.08%
QTNTQuotient Ltd+0.26+3.98%
TRIBTrinity Biotech PLC+0.19+4.26%
Data as of 4:00pm ET, 05/25/2018

Financials

Next reporting dateAugust 7, 2018
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$12.7M
Annual profit (last year)-$93.0M
Net profit margin-730.06%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Anthony S. Marucci
Chief Financial Officer &
Senior Vice President
Sam Martin
Corporate headquarters
Hampton, New Jersey

Forecasts